MapLight awards CDO 24K options at $11.245

MapLight Therapeutics, Inc. (MPLT) reported that Chief Discovery Officer Anatol Kreitzer received equity awards on August 17, 2026.

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. (MPLT) reported that Chief Discovery Officer Anatol Kreitzer received equity awards on August 17, 2026. He was granted an option to purchase 24,455 shares of voting common stock at an exercise price of $11.245 per share, expiring August 16, 2036; 1/4 of the option vests on July 1, 2027 and 1/48 vests monthly thereafter, subject to continued service. He also received 6,020 RSUs, with 1/4 vesting on July 1, 2027 and 1/16 vesting on each subsequent October 1, January 1, April 1, and July 1, subject to continued service. Following these grants, he directly holds 180,926 shares of common stock.

Insider Trade Summary

Grant/Award: 30,475 shares

Grant/Award 2 txns

Insider Kreitzer Anatol

Role Chief Discovery Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F3	24,455	$0.00	$0.00
Grant/Award	Voting Common Stock F1, F2	6,020	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 24,455 contracts (Direct); Voting Common Stock — 180,926 shares (Direct)

Footnotes (3)

1. F1. Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
2. F2. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
3. F3. 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Key Figures

Option shares granted: 24,455 shares Option exercise price: $11.245 per share Option expiration date: August 16, 2036 +4 more

7 metrics

Option shares granted 24,455 shares Employee Stock Option granted to Anatol Kreitzer on August 17, 2026

Option exercise price $11.245 per share Exercise price for the 24,455-share Employee Stock Option

Option expiration date August 16, 2036 Expiration of Employee Stock Option granted August 17, 2026

RSUs granted 6,020 units Restricted stock unit award to Anatol Kreitzer on August 17, 2026

RSU initial vesting date July 1, 2027 1/4 of RSUs vest, with remaining vesting quarterly thereafter

Option initial vesting date July 1, 2027 1/4 of option shares vest, with remaining vesting monthly thereafter

Common shares held after transaction 180,926 shares Direct voting common stock holdings of Anatol Kreitzer after awards

Key Terms

restricted stock unit ("RSU"), Employee Stock Option, vesting date

3 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest"

Employee Stock Option financial

"security_title": "Employee Stock Option (right to buy)"

An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.

vesting date financial

"thereafter, subject to the Reporting Person's continued service through each vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did MPLT grant to Chief Discovery Officer Anatol Kreitzer?

Anatol Kreitzer received an option for 24,455 shares at an exercise price of $11.245 and a restricted stock unit (RSU) award of 6,020 shares of voting common stock, all subject to service-based vesting conditions.

What is the vesting schedule for Anatol Kreitzer’s new MPLT RSU award?

The 6,020 RSUs vest with 1/4 on July 1, 2027, and 1/16 on each October 1, January 1, April 1, and July 1 thereafter, contingent on Kreitzer’s continued service through each vesting date.

How do Anatol Kreitzer’s new MPLT stock options vest and when do they expire?

The 24,455-share option vests with 1/4 on July 1, 2027 and 1/48 monthly thereafter on the same calendar day, subject to continued service, and it expires on August 16, 2036 if not exercised earlier.

What is the exercise price of Anatol Kreitzer’s new MPLT stock options?

The newly granted option allows Kreitzer to buy 24,455 shares of MPLT voting common stock at an exercise price of $11.245 per share, providing potential value if the market price exceeds that level in the future.

How many MPLT common shares does Anatol Kreitzer hold after these awards?

After the August 17, 2026 awards, Anatol Kreitzer directly holds 180,926 shares of MPLT voting common stock. This figure reflects his reported non-derivative holdings following the grant of 6,020 RSUs and does not include unexercised options.

Does each MPLT RSU granted to Anatol Kreitzer equal one share of common stock?

Yes. Each RSU in the 6,020-unit award represents a contingent right to receive one share of MPLT voting common stock, deliverable upon vesting, assuming Kreitzer continues to provide service through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/19/2026 - 06:35 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kreitzer Anatol

(Last) (First) (Middle)

C/O MAPLIGHT THERAPEUTICS, INC.

800 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MapLight Therapeutics, Inc. [ MPLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Discovery Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Voting Common Stock	08/17/2026		A		6,020(1)	A	$0(2)	180,926	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$11.245	08/17/2026		A		24,455		(3)	08/16/2036	Voting Common Stock	24,455	$0	24,455	D

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

2. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

3. 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

	/s/ Kristopher L. Hanson, Attorney-in-Fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)